![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » MGI’s DNA Sequencers Cleared in Europe, Asia-Pacific Countries
MGI’s DNA Sequencers Cleared in Europe, Asia-Pacific Countries
![ClearanceStamp_Gray.gif](https://www.fdanews.com/ext/resources/test/Device_Images6/ClearanceStamp_Gray.gif?t=1576043982&width=430)
Chinese devicemaker MGI Tech has received the CE Mark and Asia-Pacific (APAC) regulatory clearance for its G and T series DNA sequencers.
The firm’s DNBSEQ-T7, G400 and G50 sequencers earned CE Mark certification. The T7 can process 60 human genomes per day and is designed for large-scale operations, while the G400/50 sequencers are benchtop devices that can adapt to a variety of applications.
The company’s G400/50 sequencers and products in the same family also received APAC clearance, and can now be marketed in China, Japan, Australia, Singapore, Malaysia, Thailand and Vietnam.
Upcoming Events
-
21Oct